查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1603858

2030 年组织库市场预测：按产品类型、组织库类型、储存技术、应用、最终用户和地区进行的全球分析

Tissue Banking Market Forecasts to 2030 - Global Analysis By Product Type, Tissue Bank Type, Storage Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球组织库市场规模将达到 36 亿美元，预计到 2030 年将达到 57 亿美元，预测期内复合年增长率为 7.8%。

组织库收集、处理、储存和分发人体组织用于医学研究、教育和移植。组织库从已故捐赠者和接受手术的活体捐赠者那里获取组织。收集的组织经过严格的测试和处理，以确保其安全性和适用性。然后将其在受控条件下储存（通常是冷冻的），直到需要用于移植或研究目的。组织库透过为研究、教育和移植提供必要的资源，在推动医学发展和改善患者照护方面发挥关键作用。

根据世界卫生组织最近发布的资料，慢性病是世界上最大的问题之一，约占全球整体死亡人数的60%。

慢性病增加

糖尿病、心血管疾病和癌症等慢性疾病的盛行率不断上升，推动了对组织库服务的需求。由于这些疾病通常需要高级研究、个人化治疗和器官移植，因此组织库在提供必要的生物样本方面发挥关键作用。研究、诊断和治疗目的对专用组织的需求不断增长，支持了医疗保健和精准医学的进步，并推动了市场扩张。

道德问题和监管障碍

道德问题和监管障碍给市场带来了重大挑战。围绕知情同意、捐赠者隐私和生物样本潜在滥用的问题造成了道德困境。此外，有关组织收集、储存和分发的严格规定会减慢组织库的研究速度并增加营运成本。这些障碍可能会限制科学进步的样本可用性，并阻碍医学研究、再生医学和个人化治疗的进步。

老年人口增加

老年人口的增加对市场产生了重大影响。由于老年人更容易患慢性病并需要器官移植和专门治疗，因此对保存的生物样本的需求不断增加。组织库对于为研究、再生医学和移植提供组织至关重要，并有助于解决与老龄化相关的健康问题。这些人口结构的变化有助于扩大组织库市场，推动技术创新，并改善老年人的医疗保健结果。

供体组织的供应有限

供体组织供应有限是市场上的一个主要挑战，限制了研究和医疗应用的关键生物样本的供应。这种短缺减缓了科学研究，阻碍了个人化医疗的进步，并限制了需要移植或再生治疗的患者的治疗选择。捐赠者组织的短缺可能会加剧研究人员和医疗保健提供者之间的竞争，增加成本并减少获得所需治疗的机会。

COVID-19 的影响：

COVID-19 大流行扰乱了组织库市场，由于关闭、劳动力减少和医疗设施使用受限而导致样本收集、处理和分发延迟。随着重点转向与流行病相关的研究，研究活动也陷入停滞。此外，对病毒透过生物样本传播的担忧带来了新的伦理和安全考量。儘管有这些挑战，疫情凸显了组织库在推动医疗保健和研究方面的重要性。

预计消耗品领域在预测期内将是最大的。

预计消耗品领域在预测期内将占据最大的市场占有率。这包括冷冻保存溶液、储存容器、管瓶、移液管、培养基、无菌包装材料等。高品质的耗材对于保持生物样本的完整性和确保长期活力至关重要。研究和临床应用对组织样本的需求不断增长，推动了这些材料的消费不断增加，并推动市场成长。

预计移植产业在预测期内复合年增长率最高。

预计移植产业在预测期内将表现出最高的复合年增长率，因为保存的组织和器官对于移植手术的成功至关重要。组织库为需要挽救生命的移植的患者提供肾臟、角膜和骨髓等保存样本。器官移植需求的不断增长以及保存和归檔技术的进步相结合，扩大了组织库服务，改善了移植结果，并解决了全球器官短缺问题。

占比最大的地区：

由于医学研究、移植和个人化医疗的进步，预计北美地区在预测期内将占据最大的市场占有率。该地区受益于强大的医疗基础设施、强有力的法规结构以及对器官移植和再生疗法不断增长的需求。此外，慢性病的日益普及和人口老化也增加了对保存组织的需求。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现最高成长率。组织储存和处理技术的创新正在提高组织库的能力。这包括改进的冷冻保存技术和更好的储存解决方案。制定严格的法规来确保组织库的道德实践，这可以透过确保安全来促进成长，也可以透过合规成本来抑製成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球组织库市场：依产品类型

  • 组织保存介质
  • 消耗品
  • 储存系统和设备
  • 实验室器皿和设备
  • 保存和加工套件
  • 其他产品类型

第六章全球组织库市场：依组织库类型

  • 人体组织库
    • 干细胞库
    • 脐带血库
    • 骨髓库
    • 器官库
    • 皮肤库
    • 角膜银行
  • 动物组织库

第七章全球组织库市场：依储存技术分类

  • 冷冻保存
  • 冷冻的
  • 冷冻干燥
  • 冷藏
  • 灌注系统

第八章全球组织库市场：依应用分类

  • 研究与发展（R&D）
  • 再生医学
  • 诊断用途
  • 移植
  • 其他用途

第九章全球组织库市场：依最终使用者分类

  • 医院和外科中心
  • 调查机构
  • 生物技术和製药公司
  • 血液/器官库
  • 其他最终用户

第十章全球组织库市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • AMS Biotechnology Limited
  • BioLife Solutions, Inc.
  • Beckman Coulter
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Corning Incorporated
  • Helmer Scientific
  • Irvine Scientific
  • Medtronic plc
  • Paragon Bioservices, Inc.
  • The Cooper Companies, Inc.
  • TissueGenesis, Inc.
  • ViGene Biosciences, Inc.
  • Fujifilm Cellular Dynamics
Product Code: SMRC27880

According to Stratistics MRC, the Global Tissue Banking Market is accounted for $3.6 billion in 2024 and is expected to reach $5.7 billion by 2030 growing at a CAGR of 7.8% during the forecast period. Tissue banking involves the collection, processing, storage, and distribution of human tissue for medical research, education, and transplantation. Tissue banks obtain tissue from deceased donors or living donors during surgical procedures. The retrieved tissue undergoes rigorous testing and processing to ensure its safety and suitability for its intended use. It is then stored under controlled conditions, often cryogenically, until needed for transplantation or research purposes. Tissue banking plays a crucial role in advancing medical science and improving patient care by providing essential resources for research, education, and transplantation.

According to recent data released by the WHO, chronic diseases are one of the world's biggest problems, and they are responsible for roughly 60% of all fatalities globally.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, is driving the demand for tissue banking services. As these diseases often require advanced research, personalized treatment, and organ transplants, tissue banks play a crucial role in providing the necessary biological samples. This growing need for specialized tissues for research, diagnostics, and therapeutic purposes is fueling the expansion of the market, supporting advancements in healthcare and precision medicine.

Restraint:

Ethical concerns and regulatory hurdles

Ethical concerns and regulatory hurdles pose significant challenges in the market. Issues surrounding informed consent, donor privacy, and the potential misuse of biological samples create ethical dilemmas. Additionally, stringent regulations on tissue collection, storage, and distribution can slow down research and increase operational costs for tissue banks. These barriers may limit the availability of samples for scientific advancements, hindering progress in medical research, regenerative medicine, and personalized therapies.

Opportunity:

Increasing geriatric population

The increasing geriatric population is significantly impacting the market. As older adults are more susceptible to chronic diseases and require organ transplants or specialized treatments, the demand for preserved biological samples grows. Tissue banks are crucial in providing tissues for research, regenerative medicine, and transplantation, helping to address age-related health issues. This demographic shift is contributing to the expansion of the tissue banking market, driving innovation and improving healthcare outcomes for the elderly.

Threat:

Limited availability of donor tissues

The limited availability of donor tissues is a major challenge in the market, restricting the supply of critical biological samples for research and medical applications. This scarcity can lead to delays in scientific studies, hinder advancements in personalized medicine, and limit treatment options for patients requiring transplants or regenerative therapies. The shortage of donor tissues increases competition among researchers and healthcare providers, potentially driving up costs and reducing access to essential treatments.

Covid-19 Impact:

The COVID-19 pandemic disrupted the tissue banking market by causing delays in sample collection, processing, and distribution due to lockdowns, reduced workforce availability, and restricted access to medical facilities. Research activities were also slowed, as focus shifted to pandemic-related studies. Furthermore, concerns about virus transmission through biological samples raised new ethical and safety considerations. Despite these challenges, the pandemic highlighted the importance of tissue banking in advancing healthcare and research.

The consumables segment is projected to be the largest during the forecast period

The consumables segment is projected to account for the largest market share during the projection period. These include cryopreservation solutions, storage containers, vials, pipettes, culture media, and sterile packaging materials. High-quality consumables are critical for maintaining the integrity of biological samples and ensuring their long-term viability. The growing demand for tissue samples in research and clinical applications is driving increased consumption of these materials, fueling market growth.

The transplantation segment is expected to have the highest CAGR during the forecast period

The transplantation segment is expected to have the highest CAGR during the extrapolated period as stored tissues and organs are crucial for successful transplant procedures. Tissue banks provide preserved samples, such as kidneys, corneas, and bone marrow, for patients in need of life-saving transplants. The growing demand for organ transplants, coupled with advances in preservation and storage techniques, is driving the expansion of tissue banking services, improving transplant outcomes, and addressing organ shortages globally.

Region with largest share:

North America region is projected to account for the largest market share during the forecast period driven by advancements in medical research, transplantation, and personalized medicine. The region benefits from a strong healthcare infrastructure, robust regulatory frameworks, and increased demand for organ transplants and regenerative therapies. Additionally, a rising prevalence of chronic diseases and an aging population are contributing to the demand for preserved tissues.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period. Innovations in tissue preservation and processing technologies are enhancing the capabilities of tissue banks. This includes improved cryopreservation techniques and better storage solutions. Stringent regulations are being implemented to ensure ethical practices in tissue banking, which can both facilitate growth by ensuring safety and potentially restrain it due to compliance costs.

Key players in the market

Some of the key players in Tissue Banking market include AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Lonza Group AG, Corning Incorporated, Helmer Scientific, Irvine Scientific, Medtronic plc, Paragon Bioservices, Inc., The Cooper Companies, Inc., TissueGenesis, Inc., ViGene Biosciences, Inc. and Fujifilm Cellular Dynamics.

Key Developments:

In July 2023, Bio-Rad Laboratories, Inc. and QIAGEN N.Vannounced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries where advanced genomic testing has previously been limited or unavailable.

Types Covered:

  • Tissue Preservation Media
  • Consumables
  • Storage Systems & Equipment
  • Laboratory Instruments & Equipment
  • Preservation & Processing Kits
  • Other Types

Tissue Bank Types Covered:

  • Human Tissue Banks
  • Animal Tissue Banks

Storage Technologies Covered:

  • Cryopreservation
  • Freezing
  • Lyophilization
  • Cold Storage
  • Perfusion Systems

Applications Covered:

  • Research & Development (R&D)
  • Regenerative Medicine
  • Diagnostic Applications
  • Transplantation
  • Other Applications

End Users Covered:

  • Hospitals & Surgical Centers
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Blood and Organ Banks
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tissue Banking Market, By Product Type

  • 5.1 Introduction
  • 5.2 Tissue Preservation Media
  • 5.3 Consumables
  • 5.4 Storage Systems & Equipment
  • 5.5 Laboratory Instruments & Equipment
  • 5.6 Preservation & Processing Kits
  • 5.7 Other Product Types

6 Global Tissue Banking Market, By Tissue Bank Type

  • 6.1 Introduction
  • 6.2 Human Tissue Banks
    • 6.2.1 Stem Cell Banks
    • 6.2.2 Cord Blood Banks
    • 6.2.3 Bone Marrow Banks
    • 6.2.4 Organ Banks
    • 6.2.5 Skin Banks
    • 6.2.6 Corneal Banks
  • 6.3 Animal Tissue Banks

7 Global Tissue Banking Market, By Storage Technology

  • 7.1 Introduction
  • 7.2 Cryopreservation
  • 7.3 Freezing
  • 7.4 Lyophilization
  • 7.5 Cold Storage
  • 7.6 Perfusion Systems

8 Global Tissue Banking Market, By Application

  • 8.1 Introduction
  • 8.2 Research & Development (R&D)
  • 8.3 Regenerative Medicine
  • 8.4 Diagnostic Applications
  • 8.5 Transplantation
  • 8.6 Other Applications

9 Global Tissue Banking Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Surgical Centers
  • 9.3 Research Institutes
  • 9.4 Biotechnology & Pharmaceutical Companies
  • 9.5 Blood and Organ Banks
  • 9.6 Other End Users

10 Global Tissue Banking Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AMS Biotechnology Limited
  • 12.2 BioLife Solutions, Inc.
  • 12.3 Beckman Coulter
  • 12.4 Bio-Rad Laboratories Inc.
  • 12.5 Thermo Fisher Scientific Inc.
  • 12.6 Lonza Group AG
  • 12.7 Corning Incorporated
  • 12.8 Helmer Scientific
  • 12.9 Irvine Scientific
  • 12.10 Medtronic plc
  • 12.11 Paragon Bioservices, Inc.
  • 12.12 The Cooper Companies, Inc.
  • 12.13 TissueGenesis, Inc.
  • 12.14 ViGene Biosciences, Inc.
  • 12.15 Fujifilm Cellular Dynamics

List of Tables

  • Table 1 Global Tissue Banking Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Tissue Banking Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Tissue Banking Market Outlook, By Tissue Preservation Media (2022-2030) ($MN)
  • Table 4 Global Tissue Banking Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 5 Global Tissue Banking Market Outlook, By Storage Systems & Equipment (2022-2030) ($MN)
  • Table 6 Global Tissue Banking Market Outlook, By Laboratory Instruments & Equipment (2022-2030) ($MN)
  • Table 7 Global Tissue Banking Market Outlook, By Preservation & Processing Kits (2022-2030) ($MN)
  • Table 8 Global Tissue Banking Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Tissue Banking Market Outlook, By Tissue Bank Type (2022-2030) ($MN)
  • Table 10 Global Tissue Banking Market Outlook, By Human Tissue Banks (2022-2030) ($MN)
  • Table 11 Global Tissue Banking Market Outlook, By Stem Cell Banks (2022-2030) ($MN)
  • Table 12 Global Tissue Banking Market Outlook, By Cord Blood Banks (2022-2030) ($MN)
  • Table 13 Global Tissue Banking Market Outlook, By Bone Marrow Banks (2022-2030) ($MN)
  • Table 14 Global Tissue Banking Market Outlook, By Organ Banks (2022-2030) ($MN)
  • Table 15 Global Tissue Banking Market Outlook, By Skin Banks (2022-2030) ($MN)
  • Table 16 Global Tissue Banking Market Outlook, By Corneal Banks (2022-2030) ($MN)
  • Table 17 Global Tissue Banking Market Outlook, By Animal Tissue Banks (2022-2030) ($MN)
  • Table 18 Global Tissue Banking Market Outlook, By Storage Technology (2022-2030) ($MN)
  • Table 19 Global Tissue Banking Market Outlook, By Cryopreservation (2022-2030) ($MN)
  • Table 20 Global Tissue Banking Market Outlook, By Freezing (2022-2030) ($MN)
  • Table 21 Global Tissue Banking Market Outlook, By Lyophilization (2022-2030) ($MN)
  • Table 22 Global Tissue Banking Market Outlook, By Cold Storage (2022-2030) ($MN)
  • Table 23 Global Tissue Banking Market Outlook, By Perfusion Systems (2022-2030) ($MN)
  • Table 24 Global Tissue Banking Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Tissue Banking Market Outlook, By Research & Development (R&D) (2022-2030) ($MN)
  • Table 26 Global Tissue Banking Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 27 Global Tissue Banking Market Outlook, By Diagnostic Applications (2022-2030) ($MN)
  • Table 28 Global Tissue Banking Market Outlook, By Transplantation (2022-2030) ($MN)
  • Table 29 Global Tissue Banking Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 30 Global Tissue Banking Market Outlook, By End User (2022-2030) ($MN)
  • Table 31 Global Tissue Banking Market Outlook, By Hospitals & Surgical Centers (2022-2030) ($MN)
  • Table 32 Global Tissue Banking Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 33 Global Tissue Banking Market Outlook, By Biotechnology & Pharmaceutical Companies (2022-2030) ($MN)
  • Table 34 Global Tissue Banking Market Outlook, By Blood and Organ Banks (2022-2030) ($MN)
  • Table 35 Global Tissue Banking Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.